JP2002272292A - DISEASE INJURY-RESISTANT PLANT TRANSFERRED WITH WASABI gamma-THIONINE GENE - Google Patents
DISEASE INJURY-RESISTANT PLANT TRANSFERRED WITH WASABI gamma-THIONINE GENEInfo
- Publication number
- JP2002272292A JP2002272292A JP2001083526A JP2001083526A JP2002272292A JP 2002272292 A JP2002272292 A JP 2002272292A JP 2001083526 A JP2001083526 A JP 2001083526A JP 2001083526 A JP2001083526 A JP 2001083526A JP 2002272292 A JP2002272292 A JP 2002272292A
- Authority
- JP
- Japan
- Prior art keywords
- disease
- gene
- thionine
- wasabi
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 97
- 235000000760 Wasabia japonica Nutrition 0.000 title claims abstract description 72
- 201000010099 disease Diseases 0.000 title claims abstract description 32
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 32
- 241000196324 Embryophyta Species 0.000 title claims description 86
- 208000027418 Wounds and injury Diseases 0.000 title abstract 3
- 208000014674 injury Diseases 0.000 title abstract 3
- 241001293164 Eutrema japonicum Species 0.000 title 1
- 244000195452 Wasabia japonica Species 0.000 claims abstract description 71
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 37
- 235000009566 rice Nutrition 0.000 claims abstract description 36
- 238000000034 method Methods 0.000 claims abstract description 26
- 241000209094 Oryza Species 0.000 claims abstract 9
- 101000918874 Gymnadenia conopsea Defensin-like protein Proteins 0.000 claims description 28
- 239000013598 vector Substances 0.000 claims description 28
- 206010020649 Hyperkeratosis Diseases 0.000 claims description 22
- 102000004169 proteins and genes Human genes 0.000 claims description 20
- 240000003291 Armoracia rusticana Species 0.000 claims description 14
- 235000011330 Armoracia rusticana Nutrition 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 10
- 230000001766 physiological effect Effects 0.000 claims description 10
- 210000002242 embryoid body Anatomy 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 7
- 241001071795 Gentiana Species 0.000 claims description 4
- 240000008415 Lactuca sativa Species 0.000 claims description 4
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 4
- 241000220225 Malus Species 0.000 claims description 4
- 241000209140 Triticum Species 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- KUUVQVSHGLHAKZ-UHFFFAOYSA-N thionine Chemical compound C=1C=CC=CSC=CC=1 KUUVQVSHGLHAKZ-UHFFFAOYSA-N 0.000 claims 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 208000035143 Bacterial infection Diseases 0.000 claims 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims 2
- 230000006378 damage Effects 0.000 abstract 2
- 240000007594 Oryza sativa Species 0.000 description 31
- 108020004414 DNA Proteins 0.000 description 27
- 241000589158 Agrobacterium Species 0.000 description 20
- 229920001817 Agar Polymers 0.000 description 17
- 239000008272 agar Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 14
- 239000007787 solid Substances 0.000 description 12
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 11
- 241000233866 Fungi Species 0.000 description 10
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 10
- 238000011081 inoculation Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- 230000009261 transgenic effect Effects 0.000 description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 108010076830 Thionins Proteins 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- PVPBBTJXIKFICP-UHFFFAOYSA-N (7-aminophenothiazin-3-ylidene)azanium;chloride Chemical compound [Cl-].C1=CC(=[NH2+])C=C2SC3=CC(N)=CC=C3N=C21 PVPBBTJXIKFICP-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 230000008929 regeneration Effects 0.000 description 6
- 238000011069 regeneration method Methods 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 108090000848 Ubiquitin Proteins 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- AWAXZRDKUHOPBO-GUBZILKMSA-N Ala-Gln-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O AWAXZRDKUHOPBO-GUBZILKMSA-N 0.000 description 4
- CNQAFFMNJIQYGX-DRZSPHRISA-N Ala-Phe-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 CNQAFFMNJIQYGX-DRZSPHRISA-N 0.000 description 4
- XWFWAXPOLRTDFZ-FXQIFTODSA-N Ala-Pro-Ser Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O XWFWAXPOLRTDFZ-FXQIFTODSA-N 0.000 description 4
- 241000701489 Cauliflower mosaic virus Species 0.000 description 4
- UUERSUCTHOZPMG-SRVKXCTJSA-N Cys-Asn-Tyr Chemical compound SC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 UUERSUCTHOZPMG-SRVKXCTJSA-N 0.000 description 4
- MUZAUPFGPMMZSS-GUBZILKMSA-N Cys-Glu-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)N MUZAUPFGPMMZSS-GUBZILKMSA-N 0.000 description 4
- XGHYKIDVGYYHDC-JBDRJPRFSA-N Cys-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CS)N XGHYKIDVGYYHDC-JBDRJPRFSA-N 0.000 description 4
- CIMULJZTTOBOPN-WHFBIAKZSA-N Gly-Asn-Asn Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CIMULJZTTOBOPN-WHFBIAKZSA-N 0.000 description 4
- DKJWUIYLMLUBDX-XPUUQOCRSA-N Gly-Val-Cys Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)O DKJWUIYLMLUBDX-XPUUQOCRSA-N 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- WIZPFZKOFZXDQG-HTFCKZLJSA-N Ile-Ile-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O WIZPFZKOFZXDQG-HTFCKZLJSA-N 0.000 description 4
- FHPZJWJWTWZKNA-LLLHUVSDSA-N Ile-Phe-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N FHPZJWJWTWZKNA-LLLHUVSDSA-N 0.000 description 4
- UBZGNBKMIJHOHL-BZSNNMDCSA-N Leu-Leu-Phe Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 UBZGNBKMIJHOHL-BZSNNMDCSA-N 0.000 description 4
- PTRKPHUGYULXPU-KKUMJFAQSA-N Leu-Phe-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O PTRKPHUGYULXPU-KKUMJFAQSA-N 0.000 description 4
- QAHFGYLFLVGBNW-DCAQKATOSA-N Met-Ala-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN QAHFGYLFLVGBNW-DCAQKATOSA-N 0.000 description 4
- FSTWDRPCQQUJIT-NHCYSSNCSA-N Met-Val-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCSC)N FSTWDRPCQQUJIT-NHCYSSNCSA-N 0.000 description 4
- UHRNIXJAGGLKHP-DLOVCJGASA-N Phe-Ala-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O UHRNIXJAGGLKHP-DLOVCJGASA-N 0.000 description 4
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 4
- IJKNKFJZOJCKRR-GBALPHGKSA-N Thr-Trp-Ser Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CO)C(O)=O)=CNC2=C1 IJKNKFJZOJCKRR-GBALPHGKSA-N 0.000 description 4
- 108700019146 Transgenes Proteins 0.000 description 4
- ADECJAKCRKPSOR-ULQDDVLXSA-N Tyr-His-Arg Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)O ADECJAKCRKPSOR-ULQDDVLXSA-N 0.000 description 4
- WURLIFOWSMBUAR-SLFFLAALSA-N Tyr-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)C(=O)O WURLIFOWSMBUAR-SLFFLAALSA-N 0.000 description 4
- 102000044159 Ubiquitin Human genes 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 108010016616 cysteinylglycine Proteins 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 108010049041 glutamylalanine Proteins 0.000 description 4
- 108010089804 glycyl-threonine Proteins 0.000 description 4
- 229960000367 inositol Drugs 0.000 description 4
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 4
- 108010038320 lysylphenylalanine Proteins 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 108010058731 nopaline synthase Proteins 0.000 description 4
- 108010079317 prolyl-tyrosine Proteins 0.000 description 4
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 4
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 4
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 4
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 4
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 4
- 108010071207 serylmethionine Proteins 0.000 description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 4
- 229960000344 thiamine hydrochloride Drugs 0.000 description 4
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 4
- 239000011747 thiamine hydrochloride Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- XAGIMRPOEJSYER-CIUDSAMLSA-N Ala-Cys-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)N XAGIMRPOEJSYER-CIUDSAMLSA-N 0.000 description 3
- MSILNNHVVMMTHZ-UWVGGRQHSA-N Arg-His-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CN=CN1 MSILNNHVVMMTHZ-UWVGGRQHSA-N 0.000 description 3
- 208000035240 Disease Resistance Diseases 0.000 description 3
- AIGROOHQXCACHL-WDSKDSINSA-N Glu-Gly-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(O)=O AIGROOHQXCACHL-WDSKDSINSA-N 0.000 description 3
- XENGULNPUDGALZ-ZPFDUUQYSA-N Ile-Asn-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)O)N XENGULNPUDGALZ-ZPFDUUQYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229960000268 spectinomycin Drugs 0.000 description 3
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- QGNXYDHVERJIAY-ACZMJKKPSA-N Asn-Gln-Cys Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)N)N QGNXYDHVERJIAY-ACZMJKKPSA-N 0.000 description 2
- IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 2
- IMXSCCDUAFEIOE-RITPCOANSA-N D-octopine Chemical compound [O-]C(=O)[C@@H](C)[NH2+][C@H](C([O-])=O)CCCNC(N)=[NH2+] IMXSCCDUAFEIOE-RITPCOANSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- 102000005421 acetyltransferase Human genes 0.000 description 2
- 108020002494 acetyltransferase Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940088530 claforan Drugs 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 2
- 101150047832 hpt gene Proteins 0.000 description 2
- 108010002685 hygromycin-B kinase Proteins 0.000 description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- FQVLRGLGWNWPSS-BXBUPLCLSA-N (4r,7s,10s,13s,16r)-16-acetamido-13-(1h-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide Chemical compound N1C(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CC1=CN=CN1 FQVLRGLGWNWPSS-BXBUPLCLSA-N 0.000 description 1
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
- 101150021974 Adh1 gene Proteins 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- KVWLTGNCJYDJET-LSJOCFKGSA-N Ala-Arg-His Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N KVWLTGNCJYDJET-LSJOCFKGSA-N 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- XTGGTAWGUFXJSV-NAKRPEOUSA-N Arg-Cys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCN=C(N)N)N XTGGTAWGUFXJSV-NAKRPEOUSA-N 0.000 description 1
- HDHZCEDPLTVHFZ-GUBZILKMSA-N Asn-Leu-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O HDHZCEDPLTVHFZ-GUBZILKMSA-N 0.000 description 1
- BEHQTVDBCLSCBY-CFMVVWHZSA-N Asn-Tyr-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BEHQTVDBCLSCBY-CFMVVWHZSA-N 0.000 description 1
- 102100033007 Carbonic anhydrase 14 Human genes 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- VOBMMKMWSIVIOA-SRVKXCTJSA-N Cys-Lys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)N VOBMMKMWSIVIOA-SRVKXCTJSA-N 0.000 description 1
- HPZAJRPYUIHDIN-BZSNNMDCSA-N Cys-Tyr-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CS)N HPZAJRPYUIHDIN-BZSNNMDCSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- VVWWRZZMPSPVQU-KBIXCLLPSA-N Gln-Cys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)N)N VVWWRZZMPSPVQU-KBIXCLLPSA-N 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- PUUYVMYCMIWHFE-BQBZGAKWSA-N Gly-Ala-Arg Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PUUYVMYCMIWHFE-BQBZGAKWSA-N 0.000 description 1
- LBDXVCBAJJNJNN-WHFBIAKZSA-N Gly-Ser-Cys Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(O)=O LBDXVCBAJJNJNN-WHFBIAKZSA-N 0.000 description 1
- 102100036738 Guanine nucleotide-binding protein subunit alpha-11 Human genes 0.000 description 1
- 241000199695 Harmonia <beetle> Species 0.000 description 1
- NJZGEXYLSFGPHG-GUBZILKMSA-N His-Gln-Cys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N NJZGEXYLSFGPHG-GUBZILKMSA-N 0.000 description 1
- FYTCLUIYTYFGPT-YUMQZZPRSA-N His-Gly-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FYTCLUIYTYFGPT-YUMQZZPRSA-N 0.000 description 1
- 101000867862 Homo sapiens Carbonic anhydrase 14 Proteins 0.000 description 1
- 101100283445 Homo sapiens GNA11 gene Proteins 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- 238000012218 Kunkel's method Methods 0.000 description 1
- NEEOBPIXKWSBRF-IUCAKERBSA-N Leu-Glu-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O NEEOBPIXKWSBRF-IUCAKERBSA-N 0.000 description 1
- 241001330975 Magnaporthe oryzae Species 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- ODGNUUUDJONJSC-UFYCRDLUSA-N Phe-Pro-Tyr Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O ODGNUUUDJONJSC-UFYCRDLUSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 101710203193 Thaumatin-like protein Proteins 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- QPMSXSBEVQLBIL-CZRHPSIPSA-N ac1mix0p Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1.O([C@H]1[C@]2(OC)C=CC34C[C@@H]2[C@](C)(O)CCC)C2=C5[C@]41CCN(C)[C@@H]3CC5=CC=C2O QPMSXSBEVQLBIL-CZRHPSIPSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 244000000005 bacterial plant pathogen Species 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960005215 dichloroacetic acid Drugs 0.000 description 1
- 239000005546 dideoxynucleotide Substances 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 101150054900 gus gene Proteins 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 108010027338 isoleucylcysteine Proteins 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000010153 self-pollination Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、病害抵抗性植物及
びその作出方法に関する。TECHNICAL FIELD The present invention relates to a disease resistant plant and a method for producing the same.
【0002】[0002]
【従来の技術】近年、遺伝子工学技術を用いて植物に有
用遺伝子を導入し、様々な環境ストレスに対する抵抗性
植物を作出する試みが進められている。既に、低温耐性
[特開平 10-179167号公報]、乾燥耐性[Science、25
9:508-510, 1993]、農薬耐性[Trend Biotechnol. 8:6
1, 1990]など、遺伝子組換え技術によって、様々なスト
レス耐性植物が作出されている。イネにおいては、イネ
から単離したキチナーゼをコードする遺伝子をイネにお
いて過剰発現させることによってイネ病原菌であるいも
ち病に対して抵抗性を付与させた報告[Theor. Appl. Ge
net. 99: 383, 1999]や、タウマチン様タンパク質遺伝
子を過剰発現させることで紋枯病菌に対する抵抗性が増
強された報告例[Theor.Appl.Genet.98: 1138, 1999]な
どがあるが、イネのT3系統においていもち病に対する
抵抗性が維持された報告はない。2. Description of the Related Art In recent years, attempts have been made to introduce useful genes into plants using genetic engineering techniques to produce plants resistant to various environmental stresses. Already, low-temperature resistance [JP-A-10-179167], drying resistance [Science, 25
9: 508-510, 1993], pesticide resistance [Trend Biotechnol. 8: 6
1, 1990], a variety of stress-tolerant plants have been produced. In rice, a gene encoding chitinase isolated from rice was overexpressed in rice to impart resistance to blast, a rice pathogen, [Theor. Appl. Ge.
net. 99: 383, 1999], and reports that the overexpression of the thaumatin-like protein gene enhances resistance to sheath blight fungi [Theor. Appl. Genet. 98: 1138, 1999]. In addition, there is no report that resistance to blast was maintained in the T3 line of rice.
【0003】ところで、γチオニンは、病原菌の細胞膜
に穴を開け細胞内物質を溶解させることにより病原菌か
らの侵襲に対して植物体を保護する防御タンパク質の一
つである[Appl. Envir. Micro. 65: 5451, 1999]。しか
し、γチオニンをイネにおいて過剰発現させることによ
っていもち病等のイネ病原菌に対して抵抗性を付与させ
た報告はない。[0003] By the way, γ-thionine is one of protective proteins that protect plants against invasion from pathogenic bacteria by making a hole in the cell membrane of the pathogenic bacteria and dissolving intracellular substances [Appl. Envir. Micro. 65: 5451, 1999]. However, there is no report that overexpression of γ-thionine in rice imparts resistance to rice pathogens such as blast.
【0004】[0004]
【発明が解決しようとする課題】本発明は、病害抵抗性
植物及びその作出方法を提供することを目的とする。An object of the present invention is to provide a disease resistant plant and a method for producing the same.
【0005】[0005]
【課題を解決するための手段】本発明者らは、上記課題
を解決するため鋭意研究を行った結果、植物体にワサビ
γチオニン遺伝子を導入することによって植物の病害抵
抗性を向上させることに成功し、本発明を完成するに至
った。Means for Solving the Problems The present inventors have conducted intensive studies to solve the above-mentioned problems, and as a result, have been able to improve the disease resistance of plants by introducing the wasabi γ-thionin gene into plants. Successfully, the present invention has been completed.
【0006】すなわち、本発明は、ワサビγチオニン遺
伝子が導入されている病害抵抗性植物、及びワサビγチ
オニン遺伝子を、植物体に導入することを特徴とする病
害抵抗性植物の作出方法である。ここで、植物として
は、イネ、コムギ、リンドウ、リンゴ及びレタスなどが
挙げられる。また、病害としては、イモチ病、もみ枯細
菌病、灰色かび病、紋枯病、腐敗病及び斑点落葉病など
が挙げられる。That is, the present invention is a disease-resistant plant into which a wasabi γ-thionin gene has been introduced, and a method for producing a disease-resistant plant, which comprises introducing a wasabi γ-thionin gene into a plant. Here, examples of the plant include rice, wheat, gentian, apple, and lettuce. Examples of the disease include potato disease, blight bacterial rot, gray mold, sheath blight, rot, and spot leaf spot.
【0007】前記ワサビγチオニン遺伝子としては、以
下のタンパク質をコードするものが挙げられる。 (a) 配列番号2又は4で表されるアミノ酸配列からな
るタンパク質 (b) 配列番号2又は4で表されるアミノ酸配列におい
て1若しくは数個のアミノ酸が欠失、置換若しくは付加
されたアミノ酸配列からなり、かつチオニンの生理学的
活性を有するタンパク質The wasabi γ-thionine gene includes those encoding the following proteins. (a) a protein consisting of the amino acid sequence represented by SEQ ID NO: 2 or 4; (b) a protein having one or several amino acids deleted, substituted or added in the amino acid sequence represented by SEQ ID NO: 2 or 4 Having the physiological activity of thionine
【0008】さらに、前記ワサビγチオニン遺伝子とし
ては、以下の(c)又は(d)のDNAからなるものが挙げられ
る。 (c) 配列番号1又は3で表される塩基配列からなるDNA (d) 配列番号1又は3で表される塩基配列からなるDNA
とストリンジェントな条件下でハイブリダイズし、かつ
チオニンの生理学的活性を有するタンパク質をコードす
るDNA 前記ワサビγチオニン遺伝子の植物への導入は、該植物
由来の胚様体カルスへの、該ワサビγチオニン遺伝子を
含む組換えベクターの導入により行うことができる。以
下、本発明を詳細に説明する。Further, the wasabi γ-thionine gene includes the following DNA of (c) or (d). (c) DNA consisting of the nucleotide sequence represented by SEQ ID NO: 1 or 3 (d) DNA consisting of the nucleotide sequence represented by SEQ ID NO: 1 or 3
DNA that encodes a protein that hybridizes under stringent conditions and has a physiological activity of thionin is introduced into a plant by introducing the wasabi γ-thionin gene into an embryoid body callus derived from the plant. It can be performed by introducing a recombinant vector containing a thionin gene. Hereinafter, the present invention will be described in detail.
【0009】[0009]
【発明の実施の形態】本発明の病害抵抗性植物は、ワサ
ビチオニン遺伝子が導入されているトランスジェニック
植物である。本発明の病害抵抗性植物は、以下のように
して作出することができる。 1.ワサビγチオニン遺伝子の調製 まず、本発明において使用するワサビγチオニン遺伝子
を調製する。ワサビγチオニン遺伝子は、常法に従い、
ワサビ(Wasabia japonica)から調製することができ
る。すなわち、上記供給源からmRNAを調製する。例え
ば、茎、葉、根などの植物組織を、グアジニン試薬、フ
ェノール試薬等で処理してトータルRNAを分離する。次
いで、トータルRNAからオリゴdT-セルロースやセファロ
ース2Bを担体とするポリU-セファロース等を用いポリ
(A)+RNA(mRNA)を単離する。得られたmRNAを鋳型とし
てオリゴdTプライマー及び逆転写酵素を用いて一本鎖cD
NAを合成後、さらに二本鎖cDNAを合成する。得られた二
本鎖cDNAを鋳型として、公知のワサビγチオニン遺伝子
の塩基配列に基づいて設計したセンスプライマー及びア
ンチセンスプライマーを用いてポリメラーゼ連鎖反応
(PCRともいう)を行うことにより、ワサビγチオニン
をコードする増幅DNA断片を得ることができる。得られ
た増幅DNA断片は、pBlueScriptSK(+)(STRATAGENE社
製)、pCR2.1(Invitrogen社製)等の適切なベクターにサ
ブクローニングし、塩基配列の決定を行うことによっ
て、目的のワサビγチオニン遺伝子であることを確認す
る。塩基配列の決定は、ジデオキシヌクレオチド鎖終結
法等の公知手法により行うことができる。BEST MODE FOR CARRYING OUT THE INVENTION The disease resistant plant of the present invention is a transgenic plant into which a wasabithionine gene has been introduced. The disease resistant plant of the present invention can be produced as follows. 1. Preparation of Wasabi γ-Thionine Gene First, the wasabi γ-thionine gene used in the present invention is prepared. Wasabi γ-thionine gene is obtained according to a standard method.
It can be prepared from wasabi ( Wasabia japonica ). That is, mRNA is prepared from the above source. For example, plant tissues such as stems, leaves, and roots are treated with a guanidine reagent, a phenol reagent, or the like to separate total RNA. Next, poly-U-sepharose using oligo-dT-cellulose or Sepharose 2B as a carrier from total RNA
(A) + RNA (mRNA) is isolated. Single-stranded cD using oligo dT primer and reverse transcriptase with the resulting mRNA as template
After synthesizing NA, double-stranded cDNA is synthesized. Using the obtained double-stranded cDNA as a template, a polymerase chain reaction (also referred to as PCR) is performed using sense primers and antisense primers designed based on the base sequence of a known horseradish γ-thionin gene, thereby obtaining wasabi γ-thionin. Can be obtained. The resulting amplified DNA fragment was subcloned into an appropriate vector such as pBlueScriptSK (+) (manufactured by STRATAGENE), pCR2.1 (manufactured by Invitrogen), and the nucleotide sequence was determined, whereby the wasabi γ-thionin gene of interest was obtained. Make sure that The base sequence can be determined by a known method such as the dideoxynucleotide chain termination method.
【0010】配列番号1及び3にワサビγチオニン遺伝
子の塩基配列を、配列番号2及び4に前記ワサビγチオ
ニンのアミノ酸配列を示すが、当該タンパク質がチオニ
ンの生理学的活性を有する限り、当該アミノ酸配列にお
いて少なくとも1個のアミノ酸に欠失、置換、付加等の
変異が生じたタンパク質をコードする遺伝子も本発明に
おいて使用することができる。ここで、「チオニンの生
理学的活性」とは、イモチ病菌等の植物病原菌の細胞膜
に穴を開けることによる発現される抗菌活性をいう。例
えば、配列番号2又は4で表されるアミノ酸配列の少な
くとも1個、好ましくは1〜10個程度、さらに好ましく
は1〜5個のアミノ酸が欠失、置換、付加したタンパク
質をコードするDNAも、該タンパク質がチオニンの生理
学的活性が失わない限り、本発明において好適に使用す
ることができる。また、配列番号1又は3で表される塩
基配列からなるDNAからなるワサビγチオニン遺伝子と
ストリンジェントな条件下でハイブリダイズすることが
できるDNAも、チオニンの生理学的活性を有するタンパ
ク質をコードする限り本発明に使用することができる。
ストリンジェントな条件とは、例えば、ナトリウム濃度
が300〜2000mM、好ましくは600〜900mMであり、温度が4
0〜75℃、好ましくは65℃での条件をいう。なお、遺伝
子への変異の導入は、Kunkel法や Gapped duplex法等の
公知の手法又はこれに準ずる方法により、例えば部位特
異的突然変異誘発法を利用した変異導入用キット〔例え
ば、TAKARA社製Mutant-KやTAKARA社製Mutant-G〕などを
用いて、あるいは、TAKARA社製LA PCR in vitro Mutage
nesis シリーズキットを用いて行うことができる。SEQ ID NOs: 1 and 3 show the base sequence of the horseradish γ-thionine gene, and SEQ ID NOs: 2 and 4 show the amino acid sequence of the horseradish γ-thionine, as long as the protein has the physiological activity of thionin. In the present invention, a gene encoding a protein in which at least one amino acid has a mutation such as deletion, substitution, or addition can also be used in the present invention. Here, “physiological activity of thionin” refers to an antibacterial activity expressed by making a hole in the cell membrane of a plant pathogenic bacterium such as a fungus. For example, at least one, preferably about 1 to 10, and more preferably 1 to 5 amino acids of the amino acid sequence represented by SEQ ID NO: 2 or 4 is deleted, substituted, and DNA encoding a protein in which As long as the protein does not lose the physiological activity of thionine, it can be suitably used in the present invention. Further, a DNA that can hybridize under stringent conditions with a horseradish γ-thionine gene consisting of a DNA consisting of the nucleotide sequence represented by SEQ ID NO: 1 or 3 is not limited as long as it encodes a protein having the physiological activity of thionin. It can be used in the present invention.
Stringent conditions include, for example, a sodium concentration of 300 to 2000 mM, preferably 600 to 900 mM, and a temperature of 4 to 4 mM.
The condition at 0 to 75 ° C, preferably at 65 ° C. The mutation can be introduced into the gene by a known method such as the Kunkel method or the Gapped duplex method or a method equivalent thereto, for example, a mutagenesis kit using a site-directed mutagenesis method (for example, Mutant manufactured by TAKARA). -K or TAKARA Mutant-G) or TAKARA LA PCR in vitro Mutage
This can be done using the nesis series kit.
【0011】2.病害抵抗性植物の作出 遺伝子工学的手法を用いて、上記ワサビγチオニン遺伝
子を植物宿主に導入することによって、病害抵抗性植物
を作出することができる。ワサビγチオニン遺伝子の植
物体への導入は、アグロバクテリウム(Agrobacteriu
m)の感染を利用する方法やDNAの直接導入法等によって
行うことができる。アグロバクテリウムの感染を利用す
る方法には、コインテグレイティブベクター(Co-integ
rative vector)系やバイナリーベクター(Binary vect
or)系があり、直接導入法には、マイクロインジェクシ
ョン法、エレクトロポレーション法、リポソーム法等が
あり、それらの詳細な手順は、当該技術分野において公
知である。2. Production of Disease-Resistant Plants Disease-resistant plants can be produced by introducing the above horseradish γ-thionin gene into a plant host using a genetic engineering technique. Introduction of the wasabi γ-thionine gene into plants was carried out using Agrobacterium
m ) The method can be carried out by using the infection method or the direct introduction method of DNA. Methods utilizing Agrobacterium infection include co-integrative vectors (Co-integ
rative vector) and binary vectors (Binary vect)
or) direct injection methods include microinjection method, electroporation method, liposome method and the like, and their detailed procedures are known in the art.
【0012】例えば、アグロバクテリウムのバイナリー
ベクター系を用いる場合、pBI101、pBI121、pGA482等の
バイナリーベクターの境界配列(LB,RB)間に、上記1
において得られたワサビγチオニン遺伝子を挿入する。
ここで、前記ワサビγチオニン遺伝子を導入先の植物体
内で発現させるためには、前記バイナリーベクターにお
いてワサビγチオニン遺伝子の前後に、それぞれ植物用
のプロモーター、ターミネーターを配置させることが必
要である。利用可能なプロモーターとしては、カリフラ
ワーモザイクウイルス(CaMV)由来の35S転写物[Jeffer
son, R.A. et al.:The EMBO J 6:3901-3907(1987)]、
トウモロコシのユビキチン遺伝子[Christensen, A.H. e
t al.:Plant Mol. Biol. 18:675-689(1992)]、ノパリ
ン合成酵素(NOS)遺伝子、オクトピン(OCT)合成酵素遺伝
子のプロモーターなどが挙げられ、同様にターミネータ
ーとしては、前記各遺伝子のターミネーターなどが挙げ
られるが、これらに限定されるものではない。また、必
要に応じてプロモーター配列とワサビγチオニン遺伝子
との間には、遺伝子発現を増強させる機能を持つイント
ロン配列、例えばトウモロコシのアルコールデヒドロゲ
ナーゼ(Adh1)のイントロン[Genes & Development 1:11
83-1200(1987)]を導入することができる。さらに、目的
の形質転換細胞を効率的に選択するために、選択マーカ
ー遺伝子をベクター上に配置することが好ましい。その
際に使用する選択マーカーとしては、カナマイシン耐性
遺伝子(NPTII)、抗生物質ハイグロマイシンに対する抵
抗性を植物に付与するハイグロマイシンホスホトランス
フェラーゼ(htp)遺伝子及びビアラホス(bialaphos)に対
する抵抗性を付与するホスフィノスリシンアセチルトラ
ンスフェラーゼ(bar)遺伝子等が挙げられる。For example, when a binary vector system of Agrobacterium is used, the above-mentioned 1 is located between the boundary sequences (LB, RB) of the binary vector such as pBI101, pBI121, pGA482.
Insert the wasabi γ-thionine gene obtained in the above.
Here, in order to express the wasabi γ-thionin gene in the plant into which the wasabi γ-thionin gene is introduced, it is necessary to arrange a promoter and a terminator for a plant before and after the wasabi γ-thionin gene in the binary vector. Available promoters include the cauliflower mosaic virus (CaMV) 35S transcript [Jeffer
son, RA et al .: The EMBO J 6: 3901-3907 (1987)],
Corn ubiquitin gene [Christensen, AHe
18: 675-689 (1992)], the promoter of the nopaline synthase (NOS) gene, the promoter of the octopine (OCT) synthase gene, and the like. But the terminator is not limited thereto. If necessary, an intron sequence having a function of enhancing gene expression, for example, an intron of corn alcohol dehydrogenase (Adh1) [Genes & Development 1:11] may be inserted between the promoter sequence and the horseradish γ-thionin gene.
83-1200 (1987)]. Furthermore, in order to efficiently select a desired transformed cell, it is preferable to arrange a selectable marker gene on a vector. The selection markers used at this time include a kanamycin resistance gene (NPTII), a hygromycin phosphotransferase (htp) gene that confers resistance to the antibiotic hygromycin to plants, and a phosphine that confers resistance to bialaphos. Nosurisin acetyltransferase (bar) gene and the like.
【0013】次いで、得られた組換えベクターを大腸菌
中で増幅後、アグロバクテリウム・チュメファシエンス
(Agrobacterium tumefaciens)EHA101株、LBA4404株な
どに、エレクトロポレーション法、凍結融解法、三者接
合法[Nucleic Acids Research, 12:8711(1984)]等によ
って導入し、ワサビγチオニン遺伝子を含む植物感染用
アグロバクテリウムを調製する。例えば、エレクトロポ
レーション法による導入は、BioRad社製のジーン・パル
サー(Gene Pulser)等により行うことができる。組換
えベクターの導入されたアグロバクテリウム、すなわち
ワサビγチオニン遺伝子を含むアグロバクテリウムの選
抜は、選抜用薬剤を含む培地上で増殖可能な株を選択す
ることにより行うことができる。Next, the obtained recombinant vector is amplified in Escherichia coli, and then subjected to electroporation, freeze-thawing, tripartite contact with Agrobacterium tumefaciens EHA101, LBA4404, and the like. Agrobacterium for plant infection containing a horseradish γ-thionine gene is prepared by introduction by a legal method [Nucleic Acids Research, 12: 8711 (1984)] or the like. For example, introduction by the electroporation method can be performed by Gene Pulser (BioRad) or the like. Selection of Agrobacterium into which the recombinant vector has been introduced, that is, Agrobacterium containing the wasabi γ-thionine gene, can be performed by selecting a strain that can grow on a medium containing the drug for selection.
【0014】次いで、ワサビγチオニン遺伝子を含むア
グロバクテリウムを、所望の植物体に感染させる。ここ
で、植物体とは、植物培養細胞(例えば、胚様体カル
ス)、栽培植物の植物体全体、植物器官(例えば葉、花
弁、茎、根、根茎、種子等)、又は植物組織(例えば表
皮、師部、柔組織、木部、維管束等)のいずれをも意味
するものである。前記胚様体カルスは、例えばイネ(Or
yza sativa L. var. Sasanishiki)の場合、以下のよう
にして得ることができる、すなわちイネの完熟種子を次
亜塩素酸で消毒後、2,4-ジクロロ酢酸を含むND2寒天固
形培地に置床して培養する。約4〜5週間後胚盤組織よ
り生じたカルスをND2寒天固形培地に移植して約3日以
上培養することにより胚様体カルスが得られる。ワサビ
γチオニン遺伝子導入の対象となる植物種は、イネ、コ
ムギ、オオムギ、トウモロコシ等の単子葉植物、タバ
コ、リンゴ、リンドウ、レタス等の双子葉植物などが挙
げられるが、これらに限定されない。植物体への前記ア
グロバクテリウムの感染は、アグロバクテリウムの培養
液に植物体を浸漬し、数分間、室温に放置することによ
り行うことができる。Next, Agrobacterium containing the horseradish γ-thionine gene is infected to a desired plant. Here, the plant body refers to a plant cultured cell (for example, an embryoid body callus), a whole plant of a cultivated plant, a plant organ (for example, a leaf, a petal, a stem, a root, a rhizome, a seed, or the like), or a plant tissue (for example, Epidermis, phloem, parenchyma, xylem, vascular bundle, etc.). The embryoid callus is, for example, rice ( Or
In the case of yza sativa L. var. Sasanishiki), it can be obtained as follows: a rice mature seed is disinfected with hypochlorous acid and then placed on ND2 agar solid medium containing 2,4-dichloroacetic acid. And culture. After about 4 to 5 weeks, the callus generated from the scutellum tissue is transplanted to ND2 agar solid medium and cultured for about 3 days or more to obtain embryoid body callus. Plant species to which the wasabi γ-thionin gene is introduced include, but are not limited to, monocotyledonous plants such as rice, wheat, barley, and corn, and dicotyledonous plants such as tobacco, apple, gentian, and lettuce. Infection of the plant with the Agrobacterium can be carried out by immersing the plant in a culture solution of Agrobacterium and leaving it at room temperature for several minutes.
【0015】ワサビγチオニン遺伝子が導入された植物
細胞は、ワサビγチオニン遺伝子或いはその発現産物の
解析により、ワサビγチオニン遺伝子を保持する形質転
換細胞を選択することも可能であるが、より効率的に目
的の形質転換細胞を選択するためには、有効な選抜マー
カーとしては、抗生物質ハイグロマイシンに対する抵抗
性を植物に付与するハイグロマイシン・フォスフォトラ
ンスフェラーゼ(hpt)遺伝子およびビアラフォス(bia
laphos)に対する抵抗性を付与するフォスフィノスリシ
ン(Phosphinothricin)アセチルトランスフェラーゼ
(bar)遺伝子等から選ばれる1つ以上の遺伝子を使用
することができる。本発明の実施例においては、これら
の選抜マーカー遺伝子を利用した形質転換細胞の選抜効
率を高めるために、カリフラワーモザイクウイルス由来
の35Sプロモーターにhpt遺伝子を連結したバイナリーベ
クターpEKH2を構築して使用した(図1)。For the plant cells into which the wasabi γ-thionine gene has been introduced, transformed cells having the wasabi γ-thionine gene can be selected by analyzing the wasabi γ-thionine gene or its expression product, but more efficiently. In order to select a desired transformed cell, effective selection markers include a hygromycin phosphotransferase (hpt) gene that confers resistance to the antibiotic hygromycin to a plant and bialaphos (bia
One or more genes selected from phosphinothricin (Phosphinothricin) acetyltransferase (bar) gene and the like, which confer resistance to laphos, can be used. In Examples of the present invention, a binary vector pEKH2 in which the hpt gene was linked to a cauliflower mosaic virus-derived 35S promoter was constructed and used in order to enhance the selection efficiency of transformed cells using these selection marker genes ( (Fig. 1).
【0016】アグロバクテリウム感染処理を施した植物
体から、残存するアグロバクテリウムを除去後、ハイグ
ロマイシンなどの選抜用薬剤を含んだ再分化誘導用培地
に置床し培養することにより、ワサビγチオニン遺伝子
が導入された植物体を得ることができる。植物体の再生
に用いられる基本培地としては、ハイグロマイシン等の
選抜薬剤を含む寒天培地(例えば、N6SE寒天固体培地)
等が挙げられる。植物体としてイネを用いた本発明の実
施例においては、選抜培地で増殖したハイグロマイシン
耐性カルスは、ハイグロマイシン等を含むN6SE寒天固形
培地に置床し再分化を誘導した。再分化培地に移植され
たカルスは、20〜30℃、好ましくは25〜28℃で、1日あ
たり500〜2,000ルクス、好ましくは800〜1,000ルクスの
光照射下、20〜60日間、好ましくは30〜40日間培養する
ことにより、ワサビγチオニン遺伝子を含むイネ植物体
に再分化させることができる。再分化させたシュートか
らは、順化用のMSHF寒天固形培地に移して発根を促し組
換え植物体を育成する。[0016] After removing the remaining Agrobacterium from the plant subjected to the Agrobacterium infection treatment, the plant is placed in a regeneration induction medium containing a selection agent such as hygromycin and cultured to obtain wasabi γ-thionin. A plant into which the gene has been introduced can be obtained. An agar medium containing a selective agent such as hygromycin (for example, N6SE agar solid medium) is used as a basic medium for plant regeneration.
And the like. In Examples of the present invention using rice as a plant, hygromycin-resistant calli grown on a selection medium were placed on an N6SE agar solid medium containing hygromycin and the like to induce regeneration. The callus transplanted to the regeneration medium is 20 to 30 ° C., preferably 25 to 28 ° C., under light irradiation of 500 to 2,000 lux, preferably 800 to 1,000 lux per day, for 20 to 60 days, preferably 30 to 30 lux. By culturing for up to 40 days, it is possible to redifferentiate into a rice plant containing the wasabi γ-thionine gene. From the regenerated shoots, the shoots are transferred to an MSHF agar solid medium for acclimation to promote rooting and to grow recombinant plants.
【0017】上記で得られたハイグロマイシン耐性細胞
塊(カルス)およびその再分化植物体に目的とするワサ
ビγチオニン遺伝子が組み込まれていることの確認は、
これらの細胞および組織から常法にしたがってDNAを抽
出し、公知のPCR法もしくはサザン法を用いて導入した
遺伝子を検出することにより行うことができる。It was confirmed that the wasabi γ-thionine gene of interest was incorporated into the hygromycin-resistant cell mass (callus) and the regenerated plant obtained above.
DNA can be extracted from these cells and tissues according to a conventional method, and the introduced gene can be detected using a known PCR method or Southern method.
【0018】一般に、植物のゲノム中に目的遺伝子が導
入される場合、その導入場所に起因する導入遺伝子の発
現レベルの差(ポジションイフェクト)が見られること
がある。プローブとして導入遺伝子のDNA断片を用いた
ノーザン法で検定することによって、より導入遺伝子が
強く発現している形質転換体を選抜することができる。
また、ワサビγチオニン遺伝子を導入したトランスジェ
ニック植物及びその次世代植物に前記遺伝子が組み込ま
れていることの確認は、前記植物から常法に従ってDNA
を抽出し、PCR法、サザン分析等を用いて導入遺伝子を
直接検出することにより行うことができる。In general, when a target gene is introduced into the genome of a plant, a difference (position effect) in the expression level of the transgene depending on the location of the gene may be observed. By performing a test using the Northern method using a DNA fragment of the transgene as a probe, a transformant in which the transgene is more strongly expressed can be selected.
Further, it was confirmed that the gene was incorporated into the transgenic plant into which the wasabi γ-thionine gene was introduced and the next-generation plant thereof, by DNA from the plant according to a conventional method.
, And directly detecting the transgene using PCR, Southern analysis, or the like.
【0019】得られたワサビγチオニン遺伝子導入植物
体は、土壌、またはバーミュキュライト等の土壌の代用
となりうる資材を詰めた容器、もしくは水耕栽培液中で
栽培し、株分けすることにより、増殖させることができ
る。このようにして増殖されたワサビγチオニン遺伝子
導入植物も、本発明の範囲に含まれる。なお、本発明に
おいてワサビγチオニン遺伝子導入植物とは、ワサビγ
チオニン遺伝子を導入したカルスなどの細胞、植物体の
根、葉鞘、葉、花序、種子(種籾)を総称するものであ
る。The obtained wasabi γ-thionine transgenic plant is cultivated in a container filled with soil or a material capable of substituting for soil such as vermiculite or a hydroponic culture solution, and divided into strains. Can be propagated. The wasabi γ-thionin transgenic plant thus grown is also included in the scope of the present invention. In the present invention, a wasabi γ-thionin transgenic plant is wasabi γ.
It is a generic term for cells such as callus into which a thionin gene has been introduced, roots, leaf sheaths, leaves, inflorescences, and seeds (seed rice) of plants.
【0020】本発明のワサビγチオニン遺伝子導入イネ
は、自家受粉によって後代植物を作出することが可能で
あり、また、本発明遺伝子は安定して後代に遺伝する、
また、他のイネとの交雑により新たな品種を作出するた
めに本発明遺伝子導入植物を用いることができる。本発
明により得られるワサビγチオニン遺伝子導入イネは、
各種病害に対する抵抗性を有するものである。このよう
な病害としては、いもち病、もみ枯細菌病、灰色かび
病、紋枯病、腐敗病、斑点落葉病、苗立枯病、縞葉枯等
が挙げられるが、これらに限定されない。The wasabi γ-thionin transgenic rice of the present invention can produce a progeny plant by self-pollination, and the gene of the present invention is stably inherited in progeny.
In addition, the transgenic plant of the present invention can be used to produce a new variety by crossing with another rice. Wasabi γ-thionin transgenic rice obtained by the present invention,
It has resistance to various diseases. Such diseases include, but are not limited to, blast, blight bacterial rot, gray mold, sheath blight, rot, spot leaf spot, seedling blight, striped leaf blight, and the like.
【0021】[0021]
【実施例】以下に、本発明の実施例を示して具体的に説
明する。ただし、本発明の範囲はこれらの実施例に限定
されるものではない。 〔実施例1〕 ワサビγチオニン遺伝子導入用ベクター
の構築 以下のようにして、ワサビγチオニン遺伝子導入用ベク
ターを構築した。まず、スペクチマイシン耐性遺伝子を
含むSpUCベクターおよびpBI221ベクターを、それぞれ制
限酵素HindIIIおよびEcoRIで処理し、SpUCベクター中に
カリフラワーモザイクウイルス35Sプロモーター(CaMV3
5S)、β-グルクロニダーゼ遺伝子(GUS)、ノパリン合
成酵素ターミネーター(nosT)を導入し、pS221ベクタ
ーを作成した。次いで、pS221ベクターのSacIサイトにS
alIリンカーを導入して、pS221sを作成した。そこへ、p
BlueScriptSK+ベクター中にクローニングされているワ
サビγチオニン遺伝子(配列番号1)をコードするcDNA
断片を、制限酵素XbaIおよびXhoIで切断して、GUS遺伝
子と置換することでpS221sへ挿入した。これにより、タ
バコ等の双子葉植物において強力な発現を可能とするワ
サビγチオニン遺伝子導入用ベクターpS221s-WTを取得
できた。DESCRIPTION OF THE PREFERRED EMBODIMENTS The embodiments of the present invention will be specifically described below. However, the scope of the present invention is not limited to these examples. Example 1 Construction of Wasabi γ-Thionine Gene Transfer Vector A wasabi γ-thionine gene transfer vector was constructed as follows. First, the SpUC vector and pBI221 vector containing the spectimycin resistance gene were treated with restriction enzymes HindIII and EcoRI, respectively, and the cauliflower mosaic virus 35S promoter (CaMV3
5S), β-glucuronidase gene (GUS), and nopaline synthase terminator (nosT) were introduced to prepare a pS221 vector. Next, the SacI site of the pS221 vector
pS221s was created by introducing an alI linker. There, p
CDNA encoding wasabi γ-thionine gene (SEQ ID NO: 1) cloned into BlueScriptSK + vector
The fragment was cut with restriction enzymes XbaI and XhoI and inserted into pS221s by replacing the GUS gene. As a result, a horseradish γ-thionin gene transfer vector pS221s-WT capable of strong expression in dicotyledonous plants such as tobacco was obtained.
【0022】さらに、pS221s-WTベクターの35Sプロモー
ターと、pAHC17ベクターのトウモロコシのユビキチンプ
ロモーターを入れ換えるべく、以下の操作をおこなっ
た。鎖前述の操作により得られたpS221s-WT、およびプ
ラスミドpAHC17につき、各100ngをそれぞれ制限酵素Xba
IおよびPstIで処理した。具体的には、DNA溶液5ng/μl
を2μl、TEバッファーを6μl、5xHバッファーを2μ
l、10単位/μlのPstIおよびXbaIをそれぞれ1μlを加え
て混合し、37℃で1時間反応させた。反応後、pS221s-W
Tの制限酵素処理溶液1μl、pAHC17の制限酵素処理溶液
3μlをとり、滅菌蒸留水6μl、TAKARA社製DNAライゲー
ションキット(ver.2)の溶液Iを10μl加えて混合し、1
6℃一晩で反応させてライゲーションをおこなった。Further, the following operation was performed to replace the 35S promoter of the pS221s-WT vector with the maize ubiquitin promoter of the pAHC17 vector. Chain 100 ng of each of pS221s-WT and plasmid pAHC17 obtained by the above-described operation were respectively restricted with restriction enzymes Xba
Treated with I and PstI. Specifically, DNA solution 5ng / μl
2 μl, TE buffer 6 μl, 5xH buffer 2 μl
1 and 10 units / μl of PstI and XbaI were added to 1 μl each, mixed, and reacted at 37 ° C. for 1 hour. After the reaction, pS221s-W
Take 1 μl of the T restriction enzyme treatment solution and 3 μl of the pAHC17 restriction enzyme treatment solution, add 6 μl of sterile distilled water, and 10 μl of solution I of DNA ligation kit (ver. 2) manufactured by TAKARA, and mix.
Ligation was performed by reacting at 6 ° C. overnight.
【0023】1.5mlチューブにおいて-80℃で貯蔵してい
るコンピテント細胞DH5αを50μlを氷中で溶解後、上記
ライゲーション後の反応液10μlを加え、氷中に30分間
放置した。次いで、42℃で2分間のヒートショックを与
えた後、氷中に2分間維持することにより形質転換を行
った。その後、このチューブにSOC培地(20g/L バクト
トリプトン、5g/L バクト酵母エキス、0.5g/L NaCl)50
0μlを加えた後、スペクチノマイシン100mg/L含有のL
B寒天固形培地(1%バクトトリプトン、0.5%酵母エ
キス、1% NaCl、1.5%寒天)プレートに塗布し、37℃
一晩で培養した。After dissolving 50 μl of competent cells DH5α stored in a 1.5 ml tube at −80 ° C. in ice, 10 μl of the above-ligated reaction solution was added, and the mixture was left on ice for 30 minutes. Next, the cells were subjected to heat shock at 42 ° C. for 2 minutes and then kept on ice for 2 minutes to perform transformation. Then add 50 g of SOC medium (20 g / L Bacto tryptone, 5 g / L Bacto yeast extract, 0.5 g / L NaCl) to this tube.
After adding 0 μl, L containing 100 mg / L of spectinomycin
B agar solid medium (1% bactotryptone, 0.5% yeast extract, 1% NaCl, 1.5% agar)
Cultured overnight.
【0024】プレートに発生した多数のスペクチノマイ
シン耐性コロニーから、ランダムに16個選択し、それぞ
れについて滅菌した爪楊枝でコロニーの一部をかきと
り、2xLB液体培地(2%バクトトリプトン、1%酵母
エキス、2%NaCl、1.5%寒天)にて37℃一晩で振盪培
養した。From a large number of spectinomycin-resistant colonies generated on the plate, 16 were randomly selected, and a part of each colony was scraped off with a sterilized toothpick, and 2xLB liquid medium (2% bactotryptone, 1% yeast extract) was used. , 2% NaCl, 1.5% agar) at 37 ° C overnight.
【0025】培養物を4℃で15,000rpmにて5分間遠心
し、上清を取り除いた。残った沈澱物にセルRNase溶液
(50mM TrisHCl (pH7.5),10mM EDTA,100μg/ml RNase
A)を50μl加え、懸濁後、アルカリ溶液(0.2M NaOH,
1%SDS)を100μl加えて穏やかに懸濁した。さらに中
和溶液(2.55M 酢酸カリウム)を75μl加えて穏やかに
懸濁後、4℃、15,000rpmで5分間遠心し、上清を新しい
チューブに移した。上清の2.5倍量のエタノールを加え
充分に撹拌後、4℃、15,000rpmで20分歓遠心し上清を取
り除いた後、70%エタノールを加えて4℃、15,000rpmで
5分間遠心した。70%エタノール洗浄をさらにおこなっ
た後、上清を捨て、DNAである沈澱物をデシケーターで
乾燥させ、10μlのTEバッファーに溶解した。The culture was centrifuged at 15,000 rpm for 5 minutes at 4 ° C., and the supernatant was removed. Add the cell RNase solution (50 mM TrisHCl (pH 7.5), 10 mM EDTA, 100 μg / ml RNase
A), add 50 μl, suspend, and add an alkaline solution (0.2 M NaOH,
(1% SDS) was added and gently suspended. Further, 75 μl of a neutralization solution (2.55 M potassium acetate) was added thereto, and the mixture was gently suspended, followed by centrifugation at 4 ° C. and 15,000 rpm for 5 minutes, and the supernatant was transferred to a new tube. After adding 2.5 times the volume of ethanol to the supernatant and thoroughly stirring, centrifuge at 15,000 rpm for 20 minutes at 4 ° C, remove the supernatant, add 70% ethanol, and add 4% at 15,000 rpm at 4 ° C.
Centrifuged for 5 minutes. After further washing with 70% ethanol, the supernatant was discarded, and the DNA precipitate was dried in a desiccator and dissolved in 10 µl of TE buffer.
【0026】上記の方法により調製したプラスミドDNA
溶液について、目的であるユビキチンプロモーターが挿
入されたか否かを確認するため、1%アガロースゲルに
おいて電気泳動を行った。電気泳動の結果よりpS221s-W
Tプラスミドよりクローンを選択し、このプラスミドDNA
を制限酵素PstIおよびXbaIで処理した。処理溶液を電気
泳動で確認し、ユビキチンプロモーター断片である2.0k
bの位置にバンドが確認されたクローン、すなわちユビ
キチンプロモーター下流にワサビγチオニン遺伝子が正
常に連結されたプラスミドーpSubWTを分離した。次い
で、ワサビγチオニン遺伝子を含有するベクターpSubWT
およびバイナリーベクターpEKHをそれぞれ制限酵素Sse8
387Iで所定の位置を一ケ所切断し、これらをライゲーシ
ョンすることによってpEKH-SubWT(図1)を得た。The plasmid DNA prepared by the above method
The solution was subjected to electrophoresis on a 1% agarose gel to confirm whether or not the target ubiquitin promoter was inserted. PS221s-W from electrophoresis results
A clone is selected from the T plasmid and this plasmid DNA
Was treated with restriction enzymes PstI and XbaI. The treatment solution was confirmed by electrophoresis, and the ubiquitin promoter fragment of 2.0 k
A clone in which a band was confirmed at the position b, that is, a plasmid pSubWT in which the wasabi γ-thionin gene was normally ligated downstream of the ubiquitin promoter was isolated. Next, a vector pSubWT containing a wasabi γ-thionine gene was prepared.
And binary vector pEKH with restriction enzyme Sse8
A predetermined position was cut at one site with 387I, and these were ligated to obtain pEKH-SubWT (FIG. 1).
【0027】〔実施例2〕 ワサビγチオニン遺伝子の
イネへの導入と発現 (1) イネの胚様体カルスの誘導 イネ(品種:ササニシキ;Oryza sativa L. var. Sasan
ishiki)の完熟種子を1%次亜塩素酸で消毒後、ND2培地
〔KNO3(2830mg/L), (NH4)2SO4(463mg/L), KH2PO4(400m
g/L), CaCl2/2H2O(166mg/L), MgSO4/7H2O(185mg/L), Mn
SO4/4H2O (4.4mg/L), H3BO3(1.6mg/L), ZnSO4/7H2O(1.5
mg/L), KI(0.8mg/L), FeSO4/7H2O(27.8mg/L), Na2EDTA
(37.3mg/L), グリシン(2.0mg/L), ニコチン酸 (0.5mg/
L), ピリドキシン塩酸塩(0.5mg/L), チアミン 塩酸塩
(1.0mg/L), ミオイノシトール(100mg/L), ショ糖(20g/
L), 2,4-D(2mg/L), 0.9%寒天〕に置床して25℃明所で
培養した。3週間後胚盤組織由来の2〜3mmの状態の良い
カルスを選抜し、25℃明所で3日間ND2培地で培養するこ
とによって、アグロバクテリウム法に供試可能な胚様体
カルスを得た。Example 2 Introduction and Expression of Wasabi γ-Thionine Gene into Rice (1) Induction of Embryoid Callus in Rice Rice (variety: Sasanishiki; Oryza sativa L. var. Sasan)
After disinfection of ripe seeds of ishiki) with 1% hypochlorous acid, ND2 medium [KNO 3 (2830 mg / L), (NH 4 ) 2 SO 4 (463 mg / L), KH 2 PO 4 (400 m
g / L), CaCl 2 / 2H 2 O (166 mg / L), MgSO 4 / 7H 2 O (185 mg / L), Mn
SO 4 / 4H 2 O (4.4mg / L), H 3 BO 3 (1.6mg / L), ZnSO 4 / 7H 2 O (1.5
mg / L), KI (0.8 mg / L), FeSO 4 / 7H 2 O (27.8 mg / L), Na 2 EDTA
(37.3mg / L), glycine (2.0mg / L), nicotinic acid (0.5mg / L
L), pyridoxine hydrochloride (0.5mg / L), thiamine hydrochloride
(1.0mg / L), myo-inositol (100mg / L), sucrose (20g / L
L), 2,4-D (2 mg / L), 0.9% agar] and cultured at 25 ° C. in the light. After 3 weeks, callus of 2-3 mm in good condition derived from the scutellum tissue is selected and cultured in an ND2 medium for 3 days in a light place at 25 ° C. to obtain an embryoid body callus that can be used for the Agrobacterium method. Was.
【0028】(2) アグロバクテリウムへのワサビγチ
オニン遺伝子を包含するバイナリーベクターの導入 40μlずつ分注して-80℃でストックしておいた市販のア
グロバクテリウムEHA101を氷中にて溶解し、ワサビγチ
オニン遺伝子を包含するバイナリーベクターpEKH-SubWT
のプラスミドDNA溶液(0.1ng/μl)を2μl加え、静か
にピペッテイングすることで氷中に5分間放置した。次
いで、氷中において、BioRad社のGnePulser用キュベッ
トに移し、25μF、200オーム、2.5kVの設定において4.3
秒間パルスを与えた。その後速やかにSOC液体培地を1m
l加え、薬剤耐性遺伝子の発現のために28℃で1時間培
養した。培養後のアグロバクテリウムを、クロラムフェ
ニコール25ppm、カナマイシン50ppm、スペクチノマイシ
ン50ppm、を含むAB寒天固形培地に塗布し、25℃で3日
間培養することで、ワサビγチオニン遺伝子および選抜
マーカー遺伝子が導入されたアグロバクテリウムのみを
増殖させた。(2) Introduction of Binary Vector Containing Wasabi γ-Thionine Gene into Agrobacterium Commercially available Agrobacterium EHA101, which was dispensed in 40 μl portions and stored at −80 ° C., was dissolved in ice. , A binary vector pEKH-SubWT containing the wasabi γ-thionine gene
2 μl of the plasmid DNA solution (0.1 ng / μl) was added, and the mixture was left on ice for 5 minutes by gently pipetting. Then, in ice, transfer to a cuvette for BioRad GnePulser and set at 25 μF, 200 ohm, 2.5 kV at 4.3 kV.
Pulsed for seconds. Immediately afterwards, 1 m of SOC liquid medium
In addition, the cells were cultured at 28 ° C. for 1 hour for expression of the drug resistance gene. The Agrobacterium after the culture was applied to an AB agar solid medium containing 25 ppm of chloramphenicol, 50 ppm of kanamycin, and 50 ppm of spectinomycin, and cultured at 25 ° C. for 3 days to obtain a wasabi γ-thionine gene and a selectable marker gene. Only the Agrobacterium into which was introduced was grown.
【0029】(3) 胚様体カルスへの組換えDNAの導入 上記で得たアグロバクテリウムを、AB寒天固形培地に塗
布し、25℃、3日間培養する。増殖したアグロバクテリ
ウムを薬さじで掻き取り、アセトシリンゴン入りAA培地
〔AA無機塩、アミノ酸、B5ビタミン、ショ糖(20g/L)、
2,4-D(2mg/L)、カイネチン(0.2mg/L)、アセトシリンゴ
ン(10mg/L);Muller et al. 1978〕に、波長600nmにお
ける吸光度が0.15〜0.20となるように懸濁した。得られ
た懸濁液に、前記(1)で得た胚様体カルスを、軽く振盪
しながら1.5〜2分間浸漬することによって、胚様体カ
ルスにアグロバクテリウムを感染させた。浸漬後の胚様
体カルスは、滅菌したペーパータオル等で余分な水分を
除去し、N6CO寒天固形培地〔KNO3(2830mg/L), (NH4)2SO
4(463mg/L), KH2PO4(400mg/L), CaCl2/2H2O (166mg/L),
MgSO4/7H2O(185mg/L), MnSO4/4H2O(4.4mg/L), H3BO
3(1.6mg/L), ZnSO4/7H2O(1.5mg/L), KI(0.8mg/L), FeSO
4/7H2O(27.8mg/L), Na2EDTA(37.3mg/L), グリシン(2.0m
g/L), ニコチン酸(0.5mg/L), ピリドキシン塩酸塩(0.5m
g/L), チアミン塩酸塩(1.0mg/L), ミオイノシトール(10
0mg/L), ショ糖(20g/L), 2,4-D (2mg/L),アセトシリン
ゴン(10mg/L), 0.2%ゲルライト〕に置床し、25〜28℃の
暗所で3日間培養した。これによって、胚様体カルスの
ゲノム中にワサビγチオニン遺伝子および選抜マーカー
遺伝子を組み込んだ。(3) Introduction of Recombinant DNA into Embryoid Callus The Agrobacterium obtained above is applied to AB agar solid medium and cultured at 25 ° C. for 3 days. Scratch the grown Agrobacterium with a spoonful, AA medium containing acetosyringone (AA inorganic salts, amino acids, B5 vitamins, sucrose (20 g / L),
Suspended in 2,4-D (2 mg / L), kinetin (0.2 mg / L), acetosyringone (10 mg / L); Muller et al. 1978] so that the absorbance at a wavelength of 600 nm is 0.15 to 0.20. did. The embryoid body callus was infected with Agrobacterium by immersing the embryoid body callus obtained in the above (1) in the obtained suspension for 1.5 to 2 minutes with gentle shaking. After immersion, the callus of the embryoid body was removed with a sterilized paper towel or the like to remove excess water, and N6CO agar solid medium (KNO 3 (2830 mg / L), (NH 4 ) 2 SO
4 (463mg / L), KH 2 PO 4 (400mg / L), CaCl 2 / 2H 2 O (166mg / L),
MgSO 4 / 7H 2 O (185 mg / L), MnSO 4 / 4H 2 O (4.4 mg / L), H 3 BO
3 (1.6mg / L), ZnSO 4 / 7H 2 O (1.5mg / L), KI (0.8mg / L), FeSO
4 / 7H 2 O (27.8mg / L), Na 2 EDTA (37.3mg / L), glycine (2.0m
g / L), nicotinic acid (0.5mg / L), pyridoxine hydrochloride (0.5m
g / L), thiamine hydrochloride (1.0 mg / L), myo-inositol (10
0 mg / L), sucrose (20 g / L), 2,4-D (2 mg / L), acetosyringone (10 mg / L), 0.2% gellite] and placed in a dark place at 25-28 ° C. Cultured for days. As a result, the wasabi γ-thionin gene and the selection marker gene were integrated into the embryoid callus genome.
【0030】(4) ワサビγチオニン遺伝子を導入した
胚様体カルスからの植物体の再生 上記で培養した胚様体カルスから、残存するアグロバク
テリウムを除去するため、クラフォラン(500mg/L)入
り滅菌水で洗浄した。洗浄したカルスは滅菌したペーパ
ータオル等で余分な水分を除去し、ハイグロマイシン等
の選抜用マーカー薬剤を含んだN6SE寒天固形培地〔KNO3
(2830mg/L), (NH4)2SO4(463mg/L), KH2PO4 (400mg/L),
CaCl2/2H2O(166mg/L), MgSO4/7H2O(185mg/L), MnSO4/4H
2O(4.4mg/L), H3BO3(1.6mg/L), ZnSO4/7H2O(1.5mg/L),
KI(0.8mg/L), FeSO4/7H2O(27.8mg/L), Na2EDTA(37.3mg
/L), グリシン(2.0mg/L), ニコチン酸(0.5mg/L), ピリ
ドキシン塩酸塩(0.5mg/L), チアミン塩酸塩(1.0mg/L),
ミオイノシトール(100mg/L), ショ糖 (20g/L), 2,4-D(2
mg/L), アセトシリンゴン(10mg/L), 0.2%ゲルライト,
クラフォラン(500mg/L), ハイグロマイシン(50mg/L)〕
に置床した。置床後3週間、25℃、暗所で培養すること
により薬剤耐性カルスを得た。(4) Regeneration of Plant from Embryoid Callus Introduced with Wasabi γ-Thionine Gene In order to remove the remaining Agrobacterium from the embryoid callus cultured above, clafolan (500 mg / L) was added. Washed with sterile water. The washed callus was washed with a sterilized paper towel to remove excess water, and N6SE agar solid medium [KNO 3
(2830mg / L), (NH 4 ) 2 SO 4 (463mg / L), KH 2 PO 4 (400mg / L),
CaCl 2 / 2H 2 O (166mg / L), MgSO 4 / 7H 2 O (185mg / L), MnSO 4 / 4H
2 O (4.4 mg / L), H 3 BO 3 (1.6 mg / L), ZnSO 4 / 7H 2 O (1.5 mg / L),
KI (0.8 mg / L), FeSO 4 / 7H 2 O (27.8 mg / L), Na 2 EDTA (37.3 mg
/ L), glycine (2.0mg / L), nicotinic acid (0.5mg / L), pyridoxine hydrochloride (0.5mg / L), thiamine hydrochloride (1.0mg / L),
Myo-inositol (100mg / L), sucrose (20g / L), 2,4-D (2
mg / L), acetosyringone (10mg / L), 0.2% gellite,
Claforan (500 mg / L), Hygromycin (50 mg / L))
Was placed on the floor. After 3 weeks from the implantation, drug-resistant callus was obtained by culturing in the dark at 25 ° C.
【0031】上記で得た耐性カルスを、MSRE寒天固形培
地〔MS無機塩, MSビタミン, KNO3 (2830mg/L), (NH4)2S
O4(463mg/L), KH2PO4(400mg/L), CaCl2/2H2O(166mg/L),
MgSO4/7H2O(185mg/L), MnSO4/4H2O(4.4mg/L), H3BO
3(1.6mg/L), ZnSO4/7H2O (1.5mg/L), KI(0.8mg/L), FeS
O4/7H2O(27.8mg/L), Na2EDTA(37.3mg/L), グリシン(2.0
mg/L), ニコチン酸(0.5mg/L), ピリドキシン塩酸塩(0.5
mg/L), チアミン塩酸塩(1.0mg/L), ミオイノシトール(1
00mg/L), ショ糖(20g/L), ソルビトール (30g/L),カザ
ミノ酸(2g/L), NAA(1mg/L), 2,4-D(2mg/L), アセトシ
リンゴン(10mg/L),0.2%ゲルライト, クラフォラン(500
mg/L), ハイグロマイシン(50mg/L)〕に置床し、25℃、
明所で培養し、再分化を誘導した。再分化したシュート
は、MSHF寒天固形培地〔MS無機塩、MSビタミン、ショ糖
(30g/L)、ハイグロマイシン (50mg/L)、寒天 (8g/L)〕
に移して発根を促し、組換え植物体を育成した。The resistant callus obtained above was added to MSRE agar solid medium [MS inorganic salt, MS vitamin, KNO 3 (2830 mg / L), (NH 4 ) 2 S
O 4 (463mg / L), KH 2 PO 4 (400mg / L), CaCl 2 / 2H 2 O (166mg / L),
MgSO 4 / 7H 2 O (185 mg / L), MnSO 4 / 4H 2 O (4.4 mg / L), H 3 BO
3 (1.6mg / L), ZnSO 4 / 7H 2 O (1.5mg / L), KI (0.8mg / L), FeS
O 4 / 7H 2 O (27.8 mg / L), Na 2 EDTA (37.3 mg / L), glycine (2.0
mg / L), nicotinic acid (0.5 mg / L), pyridoxine hydrochloride (0.5 mg / L)
mg / L), thiamine hydrochloride (1.0 mg / L), myo-inositol (1
00mg / L), sucrose (20g / L), sorbitol (30g / L), casamino acid (2g / L), NAA (1mg / L), 2,4-D (2mg / L), acetosyringone ( 10mg / L), 0.2% gellite, claforan (500
mg / L), hygromycin (50 mg / L)
The cells were cultured in the light to induce regeneration. The redifferentiated shoots were mixed with MSHF agar solid medium (MS inorganic salts, MS vitamins, sucrose
(30 g / L), hygromycin (50 mg / L), agar (8 g / L))
To promote rooting, and cultivated recombinant plants.
【0032】上記で得られた組換え植物体から調製した
約10ngのゲノムDNAをテンプレートにしてPCR反応をおこ
ない、導入した遺伝子配列の増幅を試みた。PCR反応条
件はPCR amplification kit(TAKARA社)に従っておこな
った。具体的には、10mM Tris-HCl, 2.5mM MgCl2, 50
mM KCl, 0.01% ゼラチン (pH8.3) , dNTP (dATP, dGT
P, dCTP, dTTP) 各2.5mM 混合物, ExTaq DNA ポリメラ
ーゼ (1.25unit)およびプライマー2種類(それぞれ配
列番号5及び6に示す配列を有するオリゴヌクレオチ
ド)各2μMを混合して反応液を調製した。反応液25mLを
DNAengine PTC-200(MJ Reseach 社製)を用いて、95℃
-1分、53℃-0.5分、75℃-1分の温度条件を30回繰り返
して増幅反応をおこなった。PCR産物を常法に従い、1
%アガロースゲル電気泳動法で分析したところ、約0.5k
bのPCR産物が確認された。このバンドパターンより再生
植物個体より得られた20個体より全ての供試個体におい
てシグナルが検出され、ワサビγチオニン遺伝子が組み
込まれていることが確認された(図2)。A PCR reaction was performed using about 10 ng of genomic DNA prepared from the recombinant plant obtained above as a template to attempt to amplify the introduced gene sequence. PCR reaction conditions were performed according to a PCR amplification kit (TAKARA). Specifically, 10 mM Tris-HCl, 2.5 mM MgCl2, 50
mM KCl, 0.01% gelatin (pH8.3), dNTP (dATP, dGT
(P, dCTP, dTTP) A reaction solution was prepared by mixing a 2.5 mM mixture of each, ExTaq DNA polymerase (1.25 units) and 2 μM of each of two types of primers (oligonucleotides having the sequences shown in SEQ ID NOS: 5 and 6, respectively). 25 mL of reaction solution
95 ℃ using DNAengine PTC-200 (MJ Reseach)
An amplification reaction was carried out by repeating the temperature conditions for −1 minute, 53 ° C.-0.5 minute, and 75 ° C.-1 minute 30 times. PCR products are prepared according to the standard method.
% Agarose gel electrophoresis showed that
The PCR product of b was confirmed. From this band pattern, signals were detected in all test individuals from 20 individuals obtained from the regenerated plant individuals, and it was confirmed that the wasabi γ-thionine gene was incorporated (FIG. 2).
【0033】〔実施例3〕 形質転換イネの葉の導入さ
れたワサビγチオニン遺伝子翻訳産物の解析 ウエスタンブロット解析を行うため、形質転換植物体の
葉片よりTris-HCl(pH7.5)中で抽出した試料を、SDS-P
AGE電気泳動後、Immobilon PSQPVDF膜に転写した。3%
ゼラチン/PBSにて処理後、ワサビγチオニン遺伝子導
入イネについてはワサビγチオニン遺伝子より作成した
合成ペプチド(LEGARHGSCNYIFPYHRCICYFPC:配列番号
7)を250倍希釈した溶液で処理した。さらにTween20/
TBSで洗浄後、2000倍希釈した抗ウサギIgG-APにて処理
した。TBSで洗浄後、BCIPおよびNBTにて発色反応をおこ
ない検出した。[Example 3] Analysis of transfected wasabi γ-thionine gene into transgenic rice leaves In order to perform Western blot analysis, extraction from leaves of transformed plants was performed in Tris-HCl (pH 7.5). The sample obtained was used for SDS-P
After AGE electrophoresis, it was transferred to Immobilon PSQPVDF membrane. 3%
After treatment with gelatin / PBS, the rice with a wasabi γ-thionine gene introduced was treated with a 250-fold diluted solution of a synthetic peptide (LEGARHGSCNYIFPYHRCICYFPC: SEQ ID NO: 7) prepared from the wasabi γ-thionine gene. Tween20 /
After washing with TBS, the cells were treated with anti-rabbit IgG-AP diluted 2000-fold. After washing with TBS, a color reaction was performed with BCIP and NBT and detected.
【0034】ワサビγチオニン遺伝子導入イネのT3系統
についてウエスタンブロット解析をおこなった結果を図
3に示す。供試した全ての形質転換体T3世代の植物体
において、シグナルの強さにばらつきが見られたがシグ
ナルが確認され、T3後代においても導入したワサビγ
チオニン遺伝子由来のタンパク質の産出が確認された。FIG. 3 shows the results of Western blot analysis of the T3 strain of rice with the wasabi γ-thionine gene. In all T3 generation plants tested, the signal strength varied, but the signal was confirmed, and the wasabi γ introduced in the T3 progeny was also observed.
Production of a protein derived from the thionin gene was confirmed.
【0035】〔実施例4〕 形質転換イネの耐病性試験 以下のようにして、いもち病菌に対する耐病性試験を行
った。形質転換体T2世代の植物体10個体ずつポット栽
培にて育成した。供試した種子は、共通して次のような
処理をおこなっている。対照として用いる非形質転換体
および形質転換イネの自殖後代の種子(T1)およびハイ
グロマイシンで選抜したホモ系統(22系統)播種後3
週間のイネ植物体をいもち病接種試験に供試した。いも
ち病菌は007株を用い、胞子液を植物体に噴霧後20時間
接種箱(加湿)で放置し、その後3日間25℃(湿度90
%)で育成させた。Example 4 Disease Resistance Test of Transformed Rice A disease resistance test against blast fungus was performed as follows. Ten transformant T2 generation plants were grown by pot cultivation. The seeds tested are commonly treated as follows. 3 seeds after inoculation of seeds (T1) of inbred progeny of non-transformant and transformed rice used as control and homozygous line (22 lines) selected with hygromycin
Weekly rice plants were subjected to a blast inoculation test. For the blast fungus strain 007, spray the spore solution onto the plant and leave it in the inoculation box (humidified) for 20 hours.
%).
【0036】また別のいもち病菌に対する感受性試験と
して、いもち病菌は007株を用い、パンチ接種試験に供
試した。胞子液を植物体の葉に直径5mmのパンチで傷を
つけた表面に滴下し、接種後20時間接種箱(加湿)で放
置したた後、3日間25℃(湿度90%)で育成させ、10日
後および14日後の病徴の進展を非形質転換体ササニシキ
およびいもち病菌007株に対する真性抵抗性遺伝子を有
するツユアケの各品種との比較によっていもち病菌に対
する抵抗性を調査した。結果を図4に示した。図4から
明らかなように、ワサビγチオニン遺伝子を導入したイ
ネは導入しない同一品種のイネ(ササニシキ)に比べ
て、病徴の進展が顕著に抑制された。As another susceptibility test for blast fungus, 007 strain of blast fungus was used for punch inoculation test. The spore solution was dropped on the surface of the plant body with a 5 mm diameter punch on the leaf, left in the inoculation box (humidified) for 20 hours after inoculation, and grown at 25 ° C (humidity 90%) for 3 days. The development of the symptoms after 10 days and 14 days was examined for the resistance to the blast fungus by comparing with the non-transformant Sasanishiki and the varieties of Tsuyuake having the true resistance gene against the 007 strain of blast fungus. The results are shown in FIG. As is clear from FIG. 4, the development of the symptom was remarkably suppressed in the rice cultivated with the wasabi γ-thionine gene, as compared with the rice (Sasanishiki) of the same cultivar not introduced.
【0037】また、接種後7日の病斑の進展を図5に示
した。T2系統のいもち病菌胞子噴霧接種試験におい
て、非形質転換体のササニシキと比較して病斑の進展の
抑制が確認された系統が確認された。さらにその後代系
統を用いてパンチ接種試験をおこなったところ、非形質
転換体のササニシキと比較して病斑の進展の抑制が確認
された。これらの形質転換体においては導入したワサビ
γチオニン遺伝子由来のタンパク質の産出が確認された
ことから、導入遺伝子によりいもち病菌に対する抵抗性
が増強されたものであることが判明した。FIG. 5 shows the development of lesions 7 days after the inoculation. In the blast spore spray inoculation test of the T2 strain, a strain in which the suppression of the development of the lesion was confirmed as compared with the non-transformed Sasanishiki was confirmed. Further, when a punch inoculation test was performed using a progeny line, it was confirmed that the development of lesions was suppressed as compared with the non-transformed Sasanishiki. In these transformants, production of a protein derived from the introduced horseradish γ-thionine gene was confirmed, indicating that the introduced gene had enhanced resistance to blast fungi.
【0038】[0038]
【発明の効果】本発明により、病害抵抗性植物及びその
作出方法が提供される。According to the present invention, a disease resistant plant and a method for producing the same are provided.
【0039】[0039]
【配列表】 SEQUENCE LISTING <110> Iwate prefecture <120> Disease tolerance plants transformed by Wasabi γ-thionin gene <130> P00-0797 <160> 7 <170> PatentIn Ver. 2.0 <210> 1 <211> 243 <212> DNA <213> Wasabia japonica <220> <221> CDS <222> (1)..(240) <400> 1 atg gct aag ttt gct tct atc atc gct ctt ctc ttc gct gct ctt gtt 4 8 Met Ala Lys Phe Ala Ser Ile Ile Ala Leu Leu Phe Ala Ala Leu Val 1 5 10 15 ctc ttt tct gct ttt gaa gca cca tca atg gtg gaa gcg cag aag ttg 9 6 Leu Phe Ser Ala Phe Glu Ala Pro Ser Met Val Glu Ala Gln Lys Leu 20 25 30 tgc gag aag tca agt ggg aca tgg tca gga gtc tgt gga aac aac aat 14 4 Cys Glu Lys Ser Ser Gly Thr Trp Ser Gly Val Cys Gly Asn Asn Asn 35 40 45 gcg tgc aag aat cag tgc atc aac ctt gag gga gca cga cat gga tct 19 2 Ala Cys Lys Asn Gln Cys Ile Asn Leu Glu Gly Ala Arg His Gly Ser 50 55 60 tgc aac tat atc ttc cca tat cac aga tgt atc tgt tac ttc cca tgt 24 0 Cys Asn Tyr Ile Phe Pro Tyr His Arg Cys Ile Cys Tyr Phe Pro Cys 65 70 75 80 taa 243 <210> 2 <211> 80 <212> PRT <213> Wasabia japonica <400> 2 Met Ala Lys Phe Ala Ser Ile Ile Ala Leu Leu Phe Ala Ala Leu Val 1 5 10 15 Leu Phe Ser Ala Phe Glu Ala Pro Ser Met Val Glu Ala Gln Lys Leu 20 25 30 Cys Glu Lys Ser Ser Gly Thr Trp Ser Gly Val Cys Gly Asn Asn Asn 35 40 45 Ala Cys Lys Asn Gln Cys Ile Asn Leu Glu Gly Ala Arg His Gly Ser 50 55 60 Cys Asn Tyr Ile Phe Pro Tyr His Arg Cys Ile Cys Tyr Phe Pro Cys 65 70 75 80 <210> 3 <211> 243 <212> DNA <213> Wasabia japonica <220> <221> CDS <222> (1)..(240) <400> 3 ATG GCT AAG TTT GCT TCT ATC ATC GCT CTT CTC TTC GCT GCT CTT GTT 4 8 Met Ala Lys Phe Ala Ser Ile Ile Ala Leu Leu Phe Ala Ala Leu Val 1 5 10 15 CTC TTT TCT GCT TTT GAA GCA CCA TCA ATG GTG GAA GCG CAG AAG TTG 9 6 Leu Phe Ser Ala Phe Glu Ala Pro Ser Met Val Glu Ala Gln Lys Leu 20 25 30 TGC GAG AAG TCA AGT GGG ACA TGG TCA GGA GTC TGT GGA AAC AAC AAT 14 4 Cys Glu Lys Ser Ser Gly Thr Trp Ser Gly Val Cys Gly Asn Asn Asn 35 40 45 GCG TGC AAG CAT CAG TGC ATC AAC CTT GAG GGA GCA CGA CAT GGA TCT 19 2 Ala Cys Lys His Gln Cys Ile Asn Leu Glu Gly Ala Arg His Gly Ser 50 55 60 TGC AAC TAT ATC TTC CCA TAT CAC AGA TGT ATC TGT TAC TTC CCA TGT 24 0 Cys Asn Tyr Ile Phe Pro Tyr His Arg Cys Ile Cys Tyr Phe Pro Cys 65 70 75 80 taa 243 <210> 4 <211> 80 <212> PRT <213> Wasabia japonica <400> 4 Met Ala Lys Phe Ala Ser Ile Ile Ala Leu Leu Phe Ala Ala Leu Val 1 5 10 15 Leu Phe Ser Ala Phe Glu Ala Pro Ser Met Val Glu Ala Gln Lys Leu 20 25 30 Cys Glu Lys Ser Ser Gly Thr Trp Ser Gly Val Cys Gly Asn Asn Asn 35 40 45 Ala Cys Lys His Gln Cys Ile Asn Leu Glu Gly Ala Arg His Gly Ser 50 55 60 Cys Asn Tyr Ile Phe Pro Tyr His Arg Cys Ile Cys Tyr Phe Pro Cys 65 70 75 80 <210> 5 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> Synthetic DNA <400> 5 tgtttctttt gtcgatgctc accctgttgt ttggt 35 <210> 6 <211> <212> DNA <213> Artificial Sequence <220> <223> Synthetic DNA <400> 6 gattgaatcc tgttgccggt cttgcgatga ttatc 35 <210> 7 <211> 24 <212> PRT <213> Wasabia japonica <400> 7 Leu Glu Gly Ala Arg His Gly Ser Cys Asn Tyr Ile Phe Pro Tyr His 1 5 10 15 Arg Cys Ile Cys Tyr Phe Pro Cys 20 [Sequence List] SEQUENCE LISTING <110> Iwate prefecture <120> Disease tolerance plants transformed by Wasabi γ-thionin gene <130> P00-0797 <160> 7 <170> PatentIn Ver. 2.0 <210> 1 <211> 243 < 212> DNA <213> Wasabia japonica <220> <221> CDS <222> (1) .. (240) <400> 1 atg gct aag ttt gct tct atc atc gct ctt ctc ttc gct gct ctt gtt 4 8 Met Ala Lys Phe Ala Ser Ile Ile Ala Leu Leu Phe Ala Ala Leu Val 1 5 10 15 ctc ttt tct gct ttt gaa gca cca tca atg gtg gaa gcg cag aag ttg 9 6 Leu Phe Ser Ala Phe Glu Ala Pro Ser Met Val Glu Ala Gln Lys Leu 20 25 30 tgc gag aag tca agt ggg aca tgg tca gga gtc tgt gga aac aac aat 14 4 Cys Glu Lys Ser Ser Gly Thr Trp Ser Gly Val Cys Gly Asn Asn Asn 35 40 45 gcg tgc aag aat cag tgc atc aac ctt gag gga gca cga cat gga tct 19 2 Ala Cys Lys Asn Gln Cys Ile Asn Leu Glu Gly Ala Arg His Gly Ser 50 55 60 tgc aac tat atc ttc cca tat cac aga tgt atc tgt tac ttc cca tgt 24 0 Cys Asn Tyr Ile Phe Pro Tyr His Arg Cys Ile Cys Tyr Phe Pro Cys 65 70 75 80 taa 243 <210> 2 <211> 80 <212> PRT <213> Wasabia japonica <400> 2 Met Ala Lys Phe Ala Ser Ile Ile Ala Leu Leu Phe Ala Ala Leu Val 1 5 10 15 Leu Phe Ser Ala Phe Glu Ala Pro Ser Met Val Glu Ala Gln Lys Leu 20 25 30 Cys Glu Lys Ser Ser Gly Thr Trp Ser Gly Val Cys Gly Asn Asn Asn 35 40 45 Ala Cys Lys Asn Gln Cys Ile Asn Leu Glu Gly Ala Arg His Gly Ser 50 55 60 Cys Asn Tyr Ile Phe Pro Tyr His Arg Cys Ile Cys Tyr Phe Pro Cys 65 70 75 80 <210> 3 <211> 243 <212> DNA <213> Wasabia japonica <220> <221> CDS <222> (1) .. (240) <400> 3 ATG GCT AAG TTT GCT TCT ATC ATC GCT CTT CTC TTC GCT GCT CTT GTT 4 8 Met Ala Lys Phe Ala Ser Ile Ile Ala Leu Leu Phe Ala Ala Leu Val 1 5 10 15 CTC TTT TCT GCT TTT GAA GCA CCA TCA ATG GTG GAA GCG CAG AAG TTG 9 6 Leu Phe Ser Ala Phe Glu Ala Pro Ser Met Val Glu Ala Gln Lys Leu 20 25 30 TGC GAG AAG TCA AGT GGG ACA TGG TCA GGA GTC TGT GGA AAC AAC AAT 14 4 Cys Glu Lys Ser Ser Gly Thr Trp Ser Gly Val Cys Gly Asn Asn Asn 35 40 45 GCG TGC AAG CAT CAG TGC ATC AAC CTT GAG GGA GCA CGA CAT GGA TCT 19 2 Al a Cys Lys His Gln Cys Ile Asn Leu Glu Gly Ala Arg His Gly Ser 50 55 60 TGC AAC TAT ATC TTC CCA TAT CAC AGA TGT ATC TGT TAC TTC CCA TGT 24 0 Cys Asn Tyr Ile Phe Pro Tyr His Arg Cys Ile Cys Tyr Phe Pro Cys 65 70 75 80 taa 243 <210> 4 <211> 80 <212> PRT <213> Wasabia japonica <400> 4 Met Ala Lys Phe Ala Ser Ile Ile Ala Leu Leu Phe Ala Ala Leu Val 1 5 10 15 Leu Phe Ser Ala Phe Glu Ala Pro Ser Met Val Glu Ala Gln Lys Leu 20 25 30 Cys Glu Lys Ser Ser Gly Thr Trp Ser Gly Val Cys Gly Asn Asn Asn 35 40 45 Ala Cys Lys His Gln Cys Ile Asn Leu Glu Gly Ala Arg His Gly Ser 50 55 60 Cys Asn Tyr Ile Phe Pro Tyr His Arg Cys Ile Cys Tyr Phe Pro Cys 65 70 75 80 <210> 5 <211> 35 <212> DNA <213> Artificial Sequence <220> <223> Synthetic DNA <400> 5 tgtttctttt gtcgatgctc accctgttgt ttggt 35 <210> 6 <211> <212> DNA <213> Artificial Sequence <220> <223> Synthetic DNA <400> 6 gattgaatcc tgttgccggt cttgcgatga ttatc 35 <210> 7 <211 > 24 <212> PRT <213> Wasabia japonica <400> 7 Leu Glu Gly Ala Arg His Gly Ser Cys Asn Tyr Ile Phe Pro Tyr His 1 5 10 15 Arg Cys Ile Cys Tyr Phe Pro Cys 20
【0040】[0040]
配列番号5:合成DNA 配列番号6:合成DNA SEQ ID NO: 5: synthetic DNA SEQ ID NO: 6: synthetic DNA
【図1】ワサビγチオニン遺伝子導入用バイナリーベク
ターpEKH-SubWTの構造を示した図である。FIG. 1 is a diagram showing the structure of a binary vector pEKH-SubWT for introducing a horseradish γ-thionine gene.
【図2】T0世代のワサビγチオニン遺伝子導入イネ中
にワサビγチオニン遺伝子が存在することを示すPCRの
結果を示す電気泳動写真である。FIG. 2 is an electrophoretic photograph showing the results of PCR showing the presence of the wasabi γ-thionine gene in the rice with the wasabi γ-thionine gene of the T0 generation.
【図3】T3世代のワサビγチオニン遺伝子導入イネ中
にワサビγチオニン遺伝子が存在することを示すPCRの
結果を示す電気泳動写真である。FIG. 3 is an electrophoretic photograph showing the results of PCR showing the presence of the wasabi γ-thionin gene in the rice with the wasabi γ-thionin gene of the T3 generation.
【図4】ワサビγチオニン遺伝子を導入したイネのイモ
チ病菌に対する抵抗性を示した図である。FIG. 4 is a graph showing the resistance of a rice plant into which the wasabi γ-thionine gene has been introduced to rice blast fungus.
【図5】ワサビγチオニン遺伝子を導入したイネと導入
しなかったイネのいもち病菌接種後14日目の病徴を示し
た写真である。FIG. 5 is a set of photographs showing the symptoms of a rice with the wasabi γ-thionine gene introduced thereinto and a rice with no wasabi γ-thionine gene 14 days after inoculation of the blast fungus.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 齋藤 宏昌 岩手県北上市常盤台4−7−55 ハーモニ アスK B棟202号 (72)発明者 伊藤 美奈子 岩手県北上市中野町3−2−31 ライブラ M202号 (72)発明者 西原 昌宏 岩手県北上市村崎野16−166−1 プリン セス103号 (72)発明者 寺内 良平 岩手県北上市里分8−83 ラプラージュ 301号 (72)発明者 中村 郁郎 千葉県松戸市松戸648 千葉大学松戸宿舎 204号 Fターム(参考) 2B030 AA07 AD05 CA14 CA15 CA17 CA19 4B024 AA08 BA38 BA79 CA01 DA01 GA11 4H045 AA10 AA20 AA30 BA10 CA30 DA83 EA05 FA74 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Hiromasa Saito 4-7-55 Harmonias KB Building 202, Tokiwadai, Kitakami-shi, Iwate Prefecture (72) Inventor Minako Ito 3-2-31 Nakanocho, Kitakami-shi, Iwate M202 (72) Inventor Masahiro Nishihara 16-166-1 Murasakino, Kitakami-shi, Iwate Prefecture Princess 103 (72) Inventor Ryohei Terauchi 8-83 Ritabu, Kitakami-shi, Iwate Prefecture Laplage 301 (72) Inventor Ikuo Nakamura 648 Matsudo, Matsudo, Matsudo-shi, Chiba 204 Matsudo Dormitory, Chiba University 2F030 AA07 AD05 CA14 CA15 CA17 CA19 4B024 AA08 BA38 BA79 CA01 DA01 GA11 4H045 AA10 AA20 AA30 BA10 CA30 DA83 EA05 FA74
Claims (11)
る病害抵抗性植物。1. A disease-resistant plant into which a wasabi γ-thionine gene has been introduced.
パク質をコードするものである請求項1記載の病害抵抗
性植物。 (a) 配列番号2又は4で表されるアミノ酸配列からな
るタンパク質 (b) 配列番号2又は4で表されるアミノ酸配列におい
て1若しくは数個のアミノ酸が欠失、置換若しくは付加
されたアミノ酸配列からなり、かつチオニンの生理学的
活性を有するタンパク質2. The disease-resistant plant according to claim 1, wherein the wasabi γ-thionine gene encodes the following protein. (a) a protein consisting of the amino acid sequence represented by SEQ ID NO: 2 or 4; (b) a protein having one or several amino acids deleted, substituted or added in the amino acid sequence represented by SEQ ID NO: 2 or 4 Having the physiological activity of thionine
又は(d)のDNAからなるものである請求項1記載の病害抵
抗性植物。 (c) 配列番号1又は3で表される塩基配列からなるDNA (d) 配列番号1又は3で表される塩基配列からなるDNA
とストリンジェントな条件下でハイブリダイズし、かつ
チオニンの生理学的活性を有するタンパク質をコードす
るDNA3. The horseradish γ-thionine gene has the following (c):
Or the disease-resistant plant according to claim 1, which comprises the DNA of (d). (c) DNA consisting of the nucleotide sequence represented by SEQ ID NO: 1 or 3 (d) DNA consisting of the nucleotide sequence represented by SEQ ID NO: 1 or 3
Encoding a protein that hybridizes under stringent conditions with thionine and has the physiological activity of thionine
ゴ及びレタスからなる群から選択されるものである請求
項1〜3のいずれかに記載の病害抵抗性植物。4. The disease-resistant plant according to claim 1, wherein the plant is selected from the group consisting of rice, wheat, gentian, apple, and lettuce.
かび病、紋枯病、腐敗病及び斑点落葉病からなる群から
選択されるものである請求項1〜4のいずれかに記載の
病害抵抗性植物の作出方法。5. The disease according to any one of claims 1 to 4, wherein the disease is selected from the group consisting of rice blast, rice blast bacterial disease, gray mold, sheath blight, rot, and spot leaf spot. Method of producing disease-resistant plants.
することを特徴とする病害抵抗性植物の作出方法。6. A method for producing a disease-resistant plant, comprising introducing a wasabi γ-thionin gene into a plant.
パク質をコードするものである請求項6記載の病害抵抗
性植物の作出方法。 (a) 配列番号2又は4で表されるアミノ酸配列からな
るタンパク質 (b) 配列番号2又は4で表されるアミノ酸配列におい
て1若しくは数個のアミノ酸が欠失、置換若しくは付加
されたアミノ酸配列からなり、かつチオニンの生理学的
活性を有するタンパク質7. The method for producing a disease-resistant plant according to claim 6, wherein the horseradish γ-thionin gene encodes the following protein. (a) a protein consisting of the amino acid sequence represented by SEQ ID NO: 2 or 4; (b) a protein having one or several amino acids deleted, substituted or added in the amino acid sequence represented by SEQ ID NO: 2 or 4 Having the physiological activity of thionine
又は(d)のDNAからなるものである請求項6記載の病害抵
抗性植物の作出方法。 (c) 配列番号1又は3で表される塩基配列からなるDNA (d) 配列番号1又は3で表される塩基配列からなるDNA
とストリンジェントな条件下でハイブリダイズし、かつ
チオニンの生理学的活性を有するタンパク質をコードす
るDNA8. The horseradish γ-thionine gene has the following (c):
7. The method for producing a disease-resistant plant according to claim 6, which comprises the DNA of (d). (c) DNA consisting of the nucleotide sequence represented by SEQ ID NO: 1 or 3 (d) DNA consisting of the nucleotide sequence represented by SEQ ID NO: 1 or 3
Encoding a protein that hybridizes under stringent conditions with thionine and has the physiological activity of thionine
を、該植物由来の胚様体カルスへの、該ワサビγチオニ
ン遺伝子を含む組換えベクターの導入により行うことを
特徴とする請求項6〜8のいずれかに記載の病害抵抗性
植物の作出方法。9. The method according to claim 6, wherein the wasabi γ-thionin gene is introduced into a plant by introducing a recombinant vector containing the wasabi γ-thionin gene into an embryoid body callus derived from the plant. 8. The method for producing a disease-resistant plant according to any one of 8 above.
ンゴ及びレタスからなる群から選択されるものである請
求項6〜9のいずれかに記載の病害抵抗性植物の作出方
法。10. The method for producing a disease-resistant plant according to claim 6, wherein the plant is selected from the group consisting of rice, wheat, gentian, apple, and lettuce.
色かび病、紋枯病、腐敗病及び斑点落葉病からなる群か
ら選択されるものである請求項6〜10のいずれかに記
載の病害抵抗性植物の作出方法。11. The disease according to any one of claims 6 to 10, wherein the disease is selected from the group consisting of rice blast, rice blight bacterial disease, gray mold, sheath blight, rot, and spot leaf spot. Method of producing disease-resistant plants.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001083526A JP2002272292A (en) | 2001-03-22 | 2001-03-22 | DISEASE INJURY-RESISTANT PLANT TRANSFERRED WITH WASABI gamma-THIONINE GENE |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001083526A JP2002272292A (en) | 2001-03-22 | 2001-03-22 | DISEASE INJURY-RESISTANT PLANT TRANSFERRED WITH WASABI gamma-THIONINE GENE |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002272292A true JP2002272292A (en) | 2002-09-24 |
Family
ID=18939328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001083526A Pending JP2002272292A (en) | 2001-03-22 | 2001-03-22 | DISEASE INJURY-RESISTANT PLANT TRANSFERRED WITH WASABI gamma-THIONINE GENE |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2002272292A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10286034A (en) * | 1997-04-15 | 1998-10-27 | Iwate Pref Gov | Method for producing transgenic rice and rice produced by the method |
JPH1175594A (en) * | 1997-09-08 | 1999-03-23 | Norin Suisansyo Nogyo Seibutsu Shigen Kenkyusho | Method for producing multiple disease resistant plants using thionin gene |
JPH11313678A (en) * | 1998-04-30 | 1999-11-16 | Iwate Prefecture | Wasabi antibacterial protein gene |
JP2000166570A (en) * | 1998-12-10 | 2000-06-20 | Mitsubishi Chemicals Corp | Genes resistant to plant diseases caused by microorganisms belonging to Magnapothe grisea, plants transformed with the genes and methods for producing the same |
-
2001
- 2001-03-22 JP JP2001083526A patent/JP2002272292A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10286034A (en) * | 1997-04-15 | 1998-10-27 | Iwate Pref Gov | Method for producing transgenic rice and rice produced by the method |
JPH1175594A (en) * | 1997-09-08 | 1999-03-23 | Norin Suisansyo Nogyo Seibutsu Shigen Kenkyusho | Method for producing multiple disease resistant plants using thionin gene |
JPH11313678A (en) * | 1998-04-30 | 1999-11-16 | Iwate Prefecture | Wasabi antibacterial protein gene |
JP2000166570A (en) * | 1998-12-10 | 2000-06-20 | Mitsubishi Chemicals Corp | Genes resistant to plant diseases caused by microorganisms belonging to Magnapothe grisea, plants transformed with the genes and methods for producing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2256856T3 (en) | TRANSGENIC CELL SECTION PROCESS. | |
KR20150085846A (en) | Tal-Mediated Transfer DNA Insertion | |
JP3400050B2 (en) | Gene expression system comprising promoter region of alpha-amylase gene | |
WO2016057515A2 (en) | Genetic control of axillary bud growth in tobacco plants | |
JP4365025B2 (en) | Maize H3C4 promoter bound to first intron of rice actin, chimeric gene containing said promoter and transformed plant | |
US20030150027A1 (en) | Transgenic plants with increased seed yield, biomass and harvest index | |
James et al. | Transgenes display stable patterns of expression in apple fruit and Mendelian segregation in the progeny | |
JP4150590B2 (en) | Identification and characterization of an anthocyanin mutant (ANT1) in tomato | |
CN107012167A (en) | The expression of the transcription regulaton factor of heat tolerance can be provided | |
JP5186076B2 (en) | Engineering plant senescence using the myb gene promoter and cytokinin biosynthesis genes | |
JP5164093B2 (en) | Method for increasing resistance of rice to pathogens and pathogen-resistant rice transformants | |
JP2003511049A (en) | Method for increasing crop yield or biomass using protoporphyrinogen oxidase gene | |
KR100455621B1 (en) | Method for lowering pollen fertility by using pollen-specific zinc finger transcriptional factor genes | |
JP2002272292A (en) | DISEASE INJURY-RESISTANT PLANT TRANSFERRED WITH WASABI gamma-THIONINE GENE | |
JP4582853B2 (en) | Low temperature resistant rice introduced with glutathione-S-transferase gene | |
JP4331335B2 (en) | Cotton plant with improved cotton fiber characteristics, method for producing the same, and method for producing cotton fiber from the cotton plant | |
US20060288438A1 (en) | Novel miniature inverted-repeat transposable elements (MITEs)-like element and transcriptional activation element | |
WO2001012798A2 (en) | Male sterile plants | |
JPH07213185A (en) | Plant and method for improving sulfur-containing amino acid content | |
WO2001012799A2 (en) | Regulatory sequences for pollen specific or pollen abundant gene expression in plants | |
US7053203B1 (en) | Gene controlling ethylene synthesis | |
JP4359963B2 (en) | Plant promoter | |
JP3564537B2 (en) | Plant Ran gene mutant and method for promoting plant flowering time using the mutant | |
JP2011130697A (en) | Method of creating tomato having jointless trait | |
Wang | Isolation of phloem specific gene promoters for use in genetic engineering of insect resistance in rice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080225 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101109 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110308 |